Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

211
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
211
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

653
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
653
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

263
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
263
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

526
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
526
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

474
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
474
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

168
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
168

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating the global burden of mental health disorders associated with atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Diagnostic delay duration and determinants in hereditary leiomyomatosis and renal cell cancer: An observational study.

Journal of the American Academy of Dermatology·2026
Same author

Predictors of Fatal Anaphylaxis: A Systematic Review.

International archives of allergy and immunology·2026
Same author

Assessing and predicting cutaneous leiomyoma severity in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study.

Journal of the American Academy of Dermatology·2025
Same author

Global burden of major depressive disorder attributable to psoriasis, 2000-2021.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Response to Zheng et al: "Advances and challenges in diagnostic strategies for HLRCC-A Letter to the Editor regarding the study by Ouchene et al on HLRCC".

Journal of the American Academy of Dermatology·2025

Related Experiment Video

Updated: Nov 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Gambling With Cardiovascular Disease Risk Models: How to Choose and How to Use.

Steven A Grover1, Hiba Jekki1, Mohammed Kaouache1

  • 1McGill Comprehensive Health Improvement Program, Faculty of Medicine, McGill University, Montréal, Québec, Canada.

The Canadian Journal of Cardiology
|February 28, 2021
PubMed
Summary

Cardiovascular risk assessment improves understanding of future cardiovascular disease (CVD) risk and aids in managing hypertension and dyslipidemia. It should initiate patient discussions on CVD risks and promote adherence to healthy habits and treatments.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.5K

Related Experiment Videos

Last Updated: Nov 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.5K

Area of Science:

  • Preventive Cardiology
  • Public Health
  • Health Behavior

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality globally.
  • Effective management of modifiable risk factors like hypertension and dyslipidemia is crucial for CVD prevention.
  • Patient adherence to lifestyle changes and pharmacotherapy presents a significant challenge in chronic disease management.

Purpose of the Study:

  • To highlight the role of cardiovascular risk assessment in enhancing patient and physician understanding of future CVD risk.
  • To explore the utility of risk assessment in improving the management of hypertension and dyslipidemia.
  • To emphasize the importance of risk assessment as a catalyst for patient engagement and adherence to preventive strategies.

Main Methods:

  • The study reviews existing literature on the impact of cardiovascular risk assessment tools.
  • It analyzes the effectiveness of risk communication in patient-physician dialogues.
  • Evidence-based health promotion and risk factor management strategies are discussed in the context of risk assessment.

Main Results:

  • Cardiovascular risk assessment enhances comprehension of individual CVD risk among both patients and physicians.
  • Risk assessment facilitates improved management of key cardiovascular risk factors, including hypertension and dyslipidemia.
  • It serves as a critical first step in motivating patients towards adopting healthier lifestyles and adhering to prescribed treatments.

Conclusions:

  • Cardiovascular risk assessment is a valuable tool for initiating conversations about CVD and related conditions like diabetes.
  • Risk calculators can support long-term patient adherence by illustrating potential benefits of interventions.
  • Effective risk management necessitates combining risk assessment with evidence-based health promotion and pharmacotherapy.